BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36518606)

  • 1. Understanding cancer genetic risk assessment motivations in a remote tailored risk communication and navigation intervention randomized controlled trial.
    Le Compte CG; Lu SE; Ani J; McDougall J; Walters ST; Toppmeyer D; Boyce TW; Stroup A; Paddock L; Grumet S; Lin Y; Heidt E; Kinney AY
    Health Psychol Behav Med; 2022; 10(1):1190-1215. PubMed ID: 36518606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.
    An J; Lu SE; McDougall J; Walters ST; Lin Y; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
    Ann Behav Med; 2023 Oct; 57(11):965-977. PubMed ID: 37658805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial promoting cancer genetic risk assessment when genetic counseling cost removed: 1-year follow-up.
    An J; McDougall J; Lin Y; Lu SE; Walters ST; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
    JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38490263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
    Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
    Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
    Kinney AY; Walters ST; Lin Y; Lu SE; Kim A; Ani J; Heidt E; Le Compte CJG; O'Malley D; Stroup A; Paddock LE; Grumet S; Boyce TW; Toppmeyer DL; McDougall JA
    J Clin Oncol; 2023 May; 41(15):2767-2778. PubMed ID: 36787512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
    Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC
    JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
    Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
    BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.
    Ladd MK; Peshkin BN; Senter L; Baldinger S; Isaacs C; Segal H; Philip S; Phillips C; Shane K; Martin A; Weinstein V; Pilarski R; Jeter J; Sweet K; Hatten B; Wurtmann EJ; Phippen S; Bro D; Schwartz MD
    Transl Behav Med; 2020 May; 10(2):337-346. PubMed ID: 30418620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can tailored interventions increase mammography use among HMO women?
    Lipkus IM; Rimer BK; Halabi S; Strigo TS
    Am J Prev Med; 2000 Jan; 18(1):1-10. PubMed ID: 10808977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
    Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
    JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of 2 Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening Among Women in the Rural US: A Randomized Clinical Trial.
    Champion VL; Paskett ED; Stump TE; Biederman EB; Vachon E; Katz ML; Rawl SM; Baltic RD; Kettler CD; Seiber EE; Xu WY; Monahan PO
    JAMA Netw Open; 2023 Apr; 6(4):e2311004. PubMed ID: 37115541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
    Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial.
    Towfighi A; Cheng EM; Ayala-Rivera M; Barry F; McCreath H; Ganz DA; Lee ML; Sanossian N; Mehta B; Dutta T; Razmara A; Bryg R; Song SS; Willis P; Wu S; Ramirez M; Richards A; Jackson N; Wacksman J; Mittman B; Tran J; Johnson RR; Ediss C; Sivers-Teixeira T; Shaby B; Montoya AL; Corrales M; Mojarro-Huang E; Castro M; Gomez P; Muñoz C; Garcia D; Moreno L; Fernandez M; Lopez E; Valdez S; Haber HR; Hill VA; Rao NM; Martinez B; Hudson L; Valle NP; Vickrey BG;
    JAMA Netw Open; 2021 Feb; 4(2):e2036227. PubMed ID: 33587132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intervention Mediators in a Randomized Controlled Trial to Increase Colonoscopy Uptake Among Individuals at Increased Risk of Familial Colorectal Cancer.
    Brumbach BH; Birmingham WC; Boonyasiriwat W; Walters S; Kinney AY
    Ann Behav Med; 2017 Oct; 51(5):694-706. PubMed ID: 28236077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening.
    Katapodi MC; Northouse LL; Schafenacker AM; Duquette D; Duffy SA; Ronis DL; Anderson B; Janz NK; McLosky J; Milliron KJ; Merajver SD; Duong LM; Copeland G
    BMC Cancer; 2013 Mar; 13():97. PubMed ID: 23448100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting.
    Morgan D; Sylvester H; Lucas FL; Miesfeldt S
    Genet Med; 2010 Jan; 12(1):25-31. PubMed ID: 20027114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.